enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Esophageal candidiasis - Wikipedia

   en.wikipedia.org/wiki/Esophageal_candidiasis

   The current first-line treatment is fluconazole, 200 mg on the first day, followed by daily dosing of 100 mg for at least 21 days total. Treatment should continue for 14 days after relief of symptoms. Other therapy options include: Nystatin is an effective treatment for mild esophageal candidiasis. [2]

3. Candidiasis - Wikipedia

   en.wikipedia.org/wiki/Candidiasis

   A one-time dose of fluconazole by mouth is 90% effective in treating a vaginal yeast infection. [70] For severe nonrecurring cases, several doses of fluconazole is recommended. [20] Local treatment may include vaginal suppositories or medicated douches. Other types of yeast infections require different dosing.

4. Fluconazole - Wikipedia

   en.wikipedia.org/wiki/Fluconazole

   The treatment of non-systemic Candida infections of the vagina ("yeast infections"), throat, and mouth. Certain systemic Candida infections in people with healthy immune systems, including infections of the bloodstream, kidney, or joints. Other antifungals are usually preferred when the infection is in the heart or central nervous system, and ...

5. Vaginal yeast infection - Wikipedia

   en.wikipedia.org/wiki/Vaginal_yeast_infection

   By mouth: ibrexafungerp, fluconazole as a single dose. [4] For severe disease another dose after 3 days may be used. [27] Short-course topical formulations (i.e., single dose and regimens of 1–3 days) effectively treat uncomplicated candidal vulvovaginitis. The topically applied azole drugs are more effective than nystatin.

6. 3 Home Remedies for Yeast Infections You Should NEVER Try - AOL

   www.aol.com/3-home-remedies-yeast-infections...

   Doctors share which home remedies will actually work to help stop yeast infections, as very few can actually treat vaginal yeast infections safely.

7. Ibrexafungerp - Wikipedia

   en.wikipedia.org/wiki/Ibrexafungerp

   Ibrexafungerp is indicated for the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC). [1] [4]Ibrexafungerp is currently undergoing late-stage clinical trials for an intravenous formulation for the treatment of various fungal diseases, including life-threatening fungal infections caused primarily by Candida (including C. auris) and Aspergillus species.